Amal M. El Gayar

Nanoformulated Natural Therapeutics for Management of streptozotocin-induced Diabetes: Potential Use of Curcumin Nanoformulation

Yousra M. El‐Far, Mahmoud M. Zakaria, Amal M. El Gayar et al. · Nanomedicine · 2017 · 54 citations

Life Sciences, Biochemistry, Pharmacology +17

A Newly Developed Silymarin Nanoformulation As a Potential Antidiabetic Agent in Experimental Diabetes

Yousra M. El‐Far, Mahmoud M. Zakaria, Amal M. El Gayar et al. · Nanomedicine · 2016 · 49 citations

Medicine, Biotechnology, Pharmacology +17

Novel doxorubicin / folate-targeted trans-ferulic acid-loaded PLGA nanoparticles combination: In-vivo superiority over standard chemotherapeutic regimen for breast cancer treatment

Sahar A Helmy, Saif El-Mofty, Amal M. El Gayar et al. · Biomedicine & Pharmacotherapy · 2021 · 42 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Thymoquinone upregulates TRAIL/TRAILR2 expression and attenuates hepatocellular carcinoma in vivo model

Sahar A Helmy, Mohamed El‐Mesery, Amro El‐Karef et al. · Life Sciences · 2019 · 41 citations

Medicine, Oncology, Pharmacology +16

Selenium nanoparticles and quercetin suppress thioacetamide‐induced hepatocellular carcinoma in rats: Attenuation of inflammation involvement

Ahmed A. Mohamed, Randa A. Zaghloul, A. M. Abdelghany et al. · Journal of Biochemical and Molecular Toxicology · 2022 · 37 citations

Medicine, Oncology, Pharmacology +17